Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
424.80
+4.30 (1.02%)
At close: Jan 23, 2026
NSE:AKUMS Market Cap
NSE:AKUMS has a market cap or net worth of 65.04 billion as of January 23, 2026. Its market cap has decreased by -34.81% in one year.
Market Cap
65.04B
Enterprise Value
49.59B
Revenue
41.10B
Ranking
n/a
PE Ratio
20.51
Stock Price
424.80
Market Cap Chart
Since August 6, 2024, NSE:AKUMS's market cap has decreased from 125.32B to 65.04B, a decrease of -48.10%. That is a compound annual growth rate of -36.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 64.38B | -7.26% |
| Dec 31, 2025 | 69.42B | -30.92% |
| Dec 31, 2024 | 100.48B | -19.82% |
| Aug 6, 2024 | 125.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cohance Lifesciences | 152.87B |
| Alembic Pharmaceuticals | 150.40B |
| NATCO Pharma | 147.36B |
| Alivus Life Sciences | 105.67B |
| Strides Pharma Science | 79.24B |
| Aarti Pharmalabs | 68.23B |
| Sun Pharma Advanced Research Company | 41.80B |
| Innova Captab | 37.35B |